Sum Wai Pierre Lee

Title: The Innovations of Sum Wai Pierre Lee

Introduction

Sum Wai Pierre Lee is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 4 patents to his name, Lee's work has the potential to impact the treatment of various diseases.

Latest Patents

Among his latest patents are the "Anti-IL-6 receptor antibodies and methods of use," which provide anti-IL-6R monoclonal antibodies and related compositions. These innovations may be utilized in therapeutic methods for treating rheumatoid arthritis and other diseases. Another notable patent is the "Anti-KDR antibodies and methods of use," which offers anti-KDR monoclonal antibodies and related compositions. This invention can be applied in therapeutic methods for treating various cancers, rheumatoid arthritis, diabetic retinopathy, and other diseases associated with aberrant VEGF or KDR expression and/or activity.

Career Highlights

Sum Wai Pierre Lee is currently associated with Apexigen, Inc., where he continues to advance his research and development efforts. His work at Apexigen focuses on creating innovative solutions in the field of antibody therapeutics.

Collaborations

Lee has collaborated with notable colleagues, including Yaohuang Ke and Yongke Zhang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Sum Wai Pierre Lee's contributions to biotechnology through his patents and collaborations highlight his role as a key inventor in the field. His work promises to enhance therapeutic options for patients suffering from various diseases.